Journal
CANCER AND METASTASIS REVIEWS
Volume 30, Issue 3-4, Pages 277-294Publisher
SPRINGER
DOI: 10.1007/s10555-011-9310-3
Keywords
Cancer; Eicosanoids; Thromboxane; Prostacyclin; Prostaglandins; Inhibitors
Categories
Funding
- Department of Veterans Affairs
- NIH [2P01DK065123, 2PO1DK38226, P30DK79341-01, GM076592]
Ask authors/readers for more resources
Cancer initiation and progression are multistep events that require cell proliferation, migration, extravasation to the blood or lymphatic vessels, arrest to the metastatic site, and ultimately secondary growth. Tumor cell functions at both primary or secondary sites are controlled by many different factors, including growth factors and their receptors, chemokines, nuclear receptors, cell-cell interactions, cell-matrix interactions, as well as oxygenated metabolites of arachidonic acid. The observation that cyclooxygenases and lipoxygenases and their arachidonic acid-derived eicosanoid products (prostanoids and HETEs) are expressed and produced by tumor cells, together with the finding that these enzymes can regulate cell growth, survival, migration, and invasion, has prompted investigators to analyze the roles of these enzymes in cancer progression. In this review, we focus on the contribution of cyclooxygenase- and lipoxygenase-derived eicosanoids to tumor cell function in vitro and in vivo and discuss hope and tribulations of targeting these enzymes for cancer prevention and treatment.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available